OLYMPUSby New Odyssey
Menu
SEC registrant · CIK 0001563855

SOPHIRIS BIO INC.

SOPHIRIS BIO INC. (CIK 0001563855) reported net income of -$6.78 million (-$6,778,000) for FY2018 (2018-01-01 to 2018-12-31) and total assets of $13.2 million ($13,199,000) for FY2018 (as of 2018-12-31), as filed in its 10-K filed 2019-03-13 (accession 0001437749-19-004801).

Figures are as filed with the SEC in XBRL, in whole US dollars unless stated, for the company's own fiscal years (fiscal year ends December 31).

Data as of Oct 21, 2026 (Olympus publication) · Markdown version

  • Values are as filed by the company in its 10-K and 10-Q XBRL data. When a later filing restates a value, the latest filed value is shown and the first reported value is noted.

Identifiers

As published in the company's EDGAR submissions record.

IdentifierValue
CIK0001563855
EINnot in EDGAR (or not a valid EIN)
SIC industry code2834 Pharmaceutical Preparations
State or country of incorporationA1
Fiscal year endDecember 31
Filer categoryAccelerated filer<br>Smaller reporting company
Entity typeoperating
Olympus entity IDorg_6m9322eg0qyf79gsyf1mq4t5sq
  • The EIN is the one the filer gave to EDGAR. The SEC does not verify it; Olympus checks only that it has nine digits and a prefix the IRS assigns.

Latest annual financial metrics

The latest annual value of each standardised metric, with the filing it was taken from.

MetricValueFiscal periodPeriodFormFiledAccession numberXBRL concept
Net income-$6,778,000FY20182018-01-01 to 2018-12-3110-K2019-03-130001437749-19-004801NetIncomeLoss
Total assets$13,199,000FY2018as of 2018-12-3110-K2019-03-130001437749-19-004801Assets
Total liabilities$11,464,000FY2018as of 2018-12-3110-K2019-03-130001437749-19-004801Liabilities
Stockholders' equity$1,735,000FY2018as of 2018-12-3110-K2019-03-130001437749-19-004801StockholdersEquity
Operating cash flow-$13,457,000FY20182018-01-01 to 2018-12-3110-K2019-03-130001437749-19-004801NetCashProvidedByUsedInOperatingActivities
Diluted earnings per share-$0.23 per shareFY20182018-01-01 to 2018-12-3110-K2019-03-130001437749-19-004801EarningsPerShareBasicAndDiluted
Shares outstanding30,217,140 sharesFY2018as of 2019-03-0410-K2019-03-130001437749-19-004801EntityCommonStockSharesOutstanding
  • Accession numbers link to the filing's index on SEC EDGAR.

Revenue and net income history

Every annual revenue and net income value served for fiscal years 2009-2018, newest first, each with its filing.

MetricFiscal periodPeriodValueFormFiledAccession number
Net incomeFY20182018-01-01 to 2018-12-31-$6,778,00010-K2019-03-130001437749-19-004801
Net incomeFY20172017-01-01 to 2017-12-31-$8,628,00010-K2019-03-130001437749-19-004801
Net incomeFY20162016-01-01 to 2016-12-31-$11,164,00010-K2019-03-130001437749-19-004801
Net incomeFY20152015-01-01 to 2015-12-31-$14,197,00010-K2018-03-210001437749-18-005174
Net incomeFY20142014-01-01 to 2014-12-31-$30,712,00010-K2017-03-270001437749-17-005320
Net incomeFY20132013-01-01 to 2013-12-31-$11,149,00010-K2016-03-290001437749-16-028559

Recent 10-K and 10-Q filings

The 12 most recent 10-K, 10-Q and amendment filings in EDGAR, newest first.

FormFiledPeriod of reportAccession numberDocument
10-Q2019-11-082019-09-300001437749-19-022154sphs20190930_10q.htm
10-Q2019-08-092019-06-300001437749-19-016175sphs20190630_10q.htm
10-Q2019-05-092019-03-310001437749-19-009310sphs20190331_10q.htm
10-K2019-03-132018-12-310001437749-19-004801sphs20181231_10k.htm
10-Q2018-11-132018-09-300001437749-18-020579sphs20180930_10q.htm
10-Q2018-08-142018-06-300001437749-18-015589sphs20180630_10q.htm
10-Q2018-05-142018-03-310001437749-18-009769sphs20180331_10q.htm
10-K2018-03-212017-12-310001437749-18-005174sphs20171231_10k.htm
10-Q2017-11-092017-09-300001437749-17-018895sphs20170930_10q.htm
10-Q2017-08-102017-06-300001437749-17-014416sphs20170630_10q.htm
10-Q2017-05-152017-03-310001437749-17-009262sphs20170331_10q.htm
10-K2017-03-272016-12-310001437749-17-005320sphs20161231_10k.htm

Identifier registry

The company's identifiers in the Olympus identifier registry, each with how it was linked and its source.

SchemeValueHow linkedSourcePublished
SEC Central Index Key (CIK) · OLY-US-SEC-CIK0001563855published by the sourcedata.sec.gov/submissions/CIK0001563855.json2026-10-21

Sources

  • EDGAR submissions (nightly bulk archive) (company profile and filings) — U.S. Securities and Exchange Commission. EDGAR snapshot sha256:f7d2a4f18cb91aae, source date 2026-10-20. https://data.sec.gov/submissions/CIK0001563855.json
  • EDGAR XBRL company facts (nightly bulk archive) (financial metrics) — U.S. Securities and Exchange Commission. EDGAR snapshot sha256:01e4045aa34d7224, source date 2026-10-20. https://data.sec.gov/api/xbrl/companyfacts/CIK0001563855.json
  • Published by Olympus on Oct 21, 2026.
  • Source data: U.S. Securities and Exchange Commission (EDGAR). Values are as filed by the registrant; Olympus does not audit or adjust them.
  • Olympus is not affiliated with or endorsed by the U.S. Securities and Exchange Commission.

Get this data from the API

The same figures, with provenance on every value, from the API (free API key, reference) or from an AI agent through the Olympus MCP server.

curl
curl -s "https://api.olympus.new-odyssey.com/v1/sec/companies/0001563855" -H "X-API-Key: $OLYMPUS_API_KEY"

curl -s "https://api.olympus.new-odyssey.com/v1/sec/companies/0001563855/financials" -H "X-API-Key: $OLYMPUS_API_KEY"

curl -s "https://api.olympus.new-odyssey.com/v1/sec/companies/0001563855/filings?limit=12" -H "X-API-Key: $OLYMPUS_API_KEY"
MCP tool call
get_sec_company_financials {"cik":"1563855"}

On SEC EDGAR

About this data